Shows
The Health PulseAI for Early Detection: A New Chapter in Breast Cancer PreventionIs 2025 a pivotal inflection point for AI in health care? Dr. Connie Lehman, Co-Founder of Clairity, thinks so, and she has strong cause for optimism. Her organization’s software-as-a-medical-device product, Clairity Breast, recently received authorization from the Food and Drug Administration as the first AI platform that predicts a woman’s five-year risk of developing breast cancer.On this episode, Dr. Lehman shares her journey with Clairity, from the paper she read as a medical student that sparked the idea, to her experience navigating the new domain of image-based risk assessment with the FDA. Her current focus is o...
2025-10-2838 min
DoctorPodcasts || Cykiert FilesCLAIRITY BREAST: First A.I. tool authorized by FDA to predict 5-year breast cancer risk.#DoctorPodcasts Episode 117:Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA authorization for the first A.I.-powered mammography tool - CLAIRITY BREAST - that predicts 5-year cancer risk. It will save many lives. For details go to Clairity.comWatch all 117 DoctorPodcasts || Cykiert Files video podcast interview episodes with physicians, scientists, healthcare specialists, entrepreneurs and other experts. Please SUBSCRIBE & FOLLOW @DoctorPodcasts. Please LIKE, REPOST/QUOTE and SHARE the episodes. Send questions, comments and messages to @DoctorPodcasts. Thank you...
2025-06-3049 min